Holen Sie sich die Stockscreener-App
12.81
10.23%
-1.46
Beta Bionics Inc Aktie (BBNX) Neueste Nachrichten
UBS Adjusts Price Target on Beta Bionics to $22 From $24, Maintains Buy Rating - marketscreener.com
Beta Bionics Inc (BBNX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Beta Bionics, Inc. Revenue Breakdown – NASDAQ:BBNX - TradingView
Beta Bionics Inc (BBNX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Beta Bionics (BBNX) Stock Fair Value Falls As Medtech Reset Tempers iLet And Mint Optimism - Yahoo Finance
Beta Bionics Inc (BBNX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Beta Bionics Inc (BBNX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Beta Bionics Inc (BBNX) Institutional Confidence - TradingKey
Beta Bionics Inc (BBNX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Beta Bionics (BBNX) sees 6.9% stake reported by Divisadero Street group - Stock Titan
BBNX|Beta Bionics Inc|Price:16.097|Chg%:+0.247 - TradingKey
BBNX|Beta Bionics Inc|Price:16.140|Chg%:+0.290 - TradingKey
Beta Bionics Inc (BBNX) Balance Sheet - TradingKey
BBNX|Beta Bionics Inc|Price:16.330|Chg%:+0.200 - TradingKey
Beta Bionics (BBNX) Edges Higher as Investors Eye Key Resistance LevelPercent Below MA - dars.gov.et
BBNX Maintained by Goldman Sachs -- Price Target Raised to $19.0 - GuruFocus
Goldman Sachs Maintains Beta Bionics(BBNX.US) With Buy Rating, Raises Target Price to $19 - Moomoo
If You Invested $1,000 in Beta Bionics, Inc. (BBNX) - Stock Titan
Beta Bionics Price Target Raised to $22.00/Share From $18.00 by Truist Securities - Moomoo
Truist Raises Price Target on Beta Bionics to $22 From $18, Keeps Buy Rating - Moomoo
BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, Inc. Stockholders that it is Investigating the Company's Officers and Directors to Determine if They Violated Securities Laws and Breached Fiduciary Duties to Shareholders - AOL.com
Beta Bionics (BBNX) Edges Higher, Testing Key Resistance After Positive MomentumTRIN Signal - dars.gov.et
ETFs Investing in Beta Bionics, Inc. Stocks - TradingView
Price to earnings forward of Beta Bionics, Inc. – NASDAQ:BBNX - TradingView
Price to book forward of Beta Bionics, Inc. – NASDAQ:BBNX - TradingView
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
BBNX PE Ratio & Valuation, Is BBNX Overvalued - Intellectia AI
Beta Bionics CFO Stephen Feider sells $170k of BBNX stock By Investing.com - Investing.com South Africa
Beta Bionics CFO Stephen Feider sells $170k of BBNX stock - Investing.com
Form 4 Beta Bionics Inc For: 2 July By Investing.com - Investing.com Canada
CFO trades 10,000 Beta Bionics (BBNX) shares under Rule 10b5-1 plan - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Is Investigating Beta Bionics, Inc. (BBNX) And Encourages Investors to Connect - The National Law Review
BBNX Forecast — Price Target — Prediction for 2027 - TradingView
Beta Bionics to announce Q2 2026 financial results on July 29 - scanx.trade
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Beta Bionics Investor Alert: Johnson Fistel Reviews Potential Claims for Shareholders - PR Newswire
Beta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026 - The Manila Times
Beta Bionics sets July 29 call for Q2 2026 results - Stock Titan
Beta Bionics (BBNX) CFO sells 10,000 shares under 10b5-1 trading plan - Stock Titan
Beta Bionics: Some Stabilization In Sight (NASDAQ:BBNX) - Seeking Alpha
Beta Bionics, Inc. (BBNX) Investigation: Bronstein, Gewirtz & Gro - The National Law Review
Form 144 Beta Bionics For: 29 June By Investing.com - Investing.com Nigeria
BBNX (NASDAQ: BBNX) notice: proposed sale of 4,896 shares on 06/29/2026 - Stock Titan
Beta Bionics, Inc.(NasdaqGM: BBNX) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Beta Bionics, Inc.(NasdaqGM: BBNX) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Law firm investigates Beta Bionics for possible misleading growth disclosures affecting investors. - Pluang
Beta Bionics, Inc.(NasdaqGM:BBNX) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Beta Bionics, Inc.(NasdaqGM: BBNX) dropped from Russell 3000 Growth Benchmark - marketscreener.com
Form 144 Beta Bionics For: 26 June By Investing.com - Investing.com Australia
Form 4 Beta Bionics Inc For: 25 June By Investing.com - Investing.com Australia
BBNX (NASDAQ) insider notice: 5,104 option shares proposed for resale 06/26/2026 - Stock Titan
Beta Bionics, Inc. Actuals & Estimates (BOATS:BBNX) - TradingView
Insider Sell: Mark Hopman Sells Shares of Beta Bionics Inc (BBNX) - GuruFocus
Beta bionics CCO Mark Hopman sells $18,880 in stock By Investing.com - Investing.com Australia
Beta bionics CCO Mark Hopman sells $18,880 in stock - Investing.com
Beta Bionics director Christy Jones sells $21,090 in stock - Investing.com
1.04%
11.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):